Byju's acquisitions, Revenue, Byju Raveendran, Byju's acquires Epic, Byju's funding, ipo, epic, byju's, US, bought brick-and-mortar coaching network, acquired Osmo, on a fundraising spree, raised $1 billion in 2020, having acquired , Toppr, news reports, Zomato, Paytm, Mobikwik

Edtech major Byju’s has acquired US-based kids learning platform

Epic

in a $500 million cash-and-stock deal, making this its second-biggest acquisition after it bought brick-and-mortar coaching network Aakash Institute for close to $1 billion earlier this year.

The Epic acquisition is part of Byju’s big foray into the overseas market where it expects annual revenue of $300 million this financial year, cofounder Byju Raveendran told ET. In 2019, it had acquired Osmo, a US-based maker of educational games, for $120 million. The Bengaluru-based startup aims to invest around $1 billion in North America over the next couple of years, the company said.

Founded by Suren Markosian and Kevin Donahue, Epic has a user base of 50 million kids in the US who access digital books for free as well as through Epic’s subscriptions. “It is the largest B2C (business-to-consumer) edtech company in the K-12 segment and has a strong product capability that fits well into our overall plan of building an edtech ecosystem,” said Raveendran. Epic had around 20 million users in total in 2019 and grew fast over the last two years.

Markosian and Donahue will continue to run the business.

Byju’s has been on a fundraising spree since last year as it has been using this capital to finance its large-sized acquisitions. After having raised $1 billion in 2020 from global and domestic investors, the decacorn has mopped up almost $1.5 billion from investors such as UBS Group, Blackstone, Abu Dhabi sovereign fund ADQ and others in the last few months.

“In some of the new markets, we will be in a growth phase and we will invest to build similar brand and sector awareness (like it did India). With strong organic growth and these acquisitions, we will start adding significant numbers in our total revenue and you will see us accelerating over the next many years even on a large base,” Raveendran said. According to him Byju’s remains well capitalised and the India business is profitable besides generating cash.

“India’s growth is getting accelerated with Byju’s growth and Aakash. With Byju’s Future School nicely scaling (abroad), we will have three businesses overseas that will have $100 million revenue,” he added.

Byju’s is expected to see its revenues rise more than 100% in the current financial year. The company is estimated to have closed FY21 with revenue of Rs 5,600 crore.

Byju’s acquisitions in India have also triggered consolidation here. After having acquired WhiteHat Jr, Scholr, Osmo and Toppr, it is in talks to scoop up Gradeup and Great Learning, recent news reports said. Sources said the company is likely to announce the closure of the Toppr deal in the coming weeks.

At a time when many top-tier startups and tech companies like Zomato, Paytm and Mobikwik are going public, Raveendran said Byju’s is looking at an IPO timeline of 15-18 months but that’s not set in stone as it still sees strong interest from investors in the private markets to raise capital.

The Indian edtech sector is projected to become a $30 billion industry in 10 years, according to a recent report by transaction advisory firm RBSA Advisors.

Some of Byju’s early backers include Lightspeed Venture Partners, Qatar Investment Authority, Owl Ventures, General Atlantic, Tiger Global, Tencent, Verlinvest and Sofina.


Japan travel news, japan travel guides, japan holiday destinations and japan reviews

LATEST NEWS

NEWS RELATED

Subscribe to Glenmark Life Sciences: Ajcon Global

Representative image Ajcon Global IPO report on Glenmark Life Sciences Glenmark Life Sciences Limited (“GLS”) was incorporated on 23rd June, 2011. GLS is a wholly-owned subsidiary of the Promoter, Glenmark Pharmaceuticals Ltd. GLS is a leading developer and manufacturer of select high value, noncommoditized active pharmaceutical ingredients (“APIs”) in chronic…

Read more: Subscribe to Glenmark Life Sciences: Ajcon Global

Subscribe to Glenmark Life Sciences: Choice Equity Broking

Choice Equity Broking IPO report on Glenmark Life Sciences Glenmark Life Sciences Ltd. (GLS), the subsidiary of pharma major Glenmark Pharmaceuticals Ltd., is planning to raise up to Rs. 1,500cr through an IPO, which opens on 27th Jul. and closes on 29th Jul. 2021. The price band is Rs. 695…

Read more: Subscribe to Glenmark Life Sciences: Choice Equity Broking

Grofers forays into instant delivery, delivers to 7,000 households within 15 mins

Albinder Dhindsa, Co-founder and CEO, Grofers Announcing the company’s foray into instant delivery, Albinder Dhindsa = the co-founder and chief executive of online grocery delivery firm Grofers  – said on July 27  that it had delivered to over 7,000 households in 15 minutes a day before. The announcement came ahead of raising…

Read more: Grofers forays into instant delivery, delivers to 7,000 households within 15 mins

Trifecta Capital announces close of first tranche of equity fund, raises $130 million

Representative image Trifecta Capital has announced the first close of its late-stage venture capital fund Trifecta Leaders Fund I raising $130 million with participation from domestic investors including large corporates, insurance companies, family offices, ultra-high net individuals and entrepreneurs. Existing investors of Trifecta Capital’s Venture Debt Funds have also made significant investments in…

Read more: Trifecta Capital announces close of first tranche of equity fund, raises $130 million

Want to IPO in 12-18 months, going public is a big aspiration: Byju Raveendran

Byju Raveendran What is Byju’s? Depending on whom you ask, answers range from a venture capital fund, a private equity fund, a proxy for the government’s education policy (or lack of it), or everyone’s favourite subject of memes or criticism. Byju’s, which has spent over $2 billion in acquisitions the…

Read more: Want to IPO in 12-18 months, going public is a big aspiration: Byju Raveendran

Exclusive | China ed-tech crackdown will benefit India the most: Byju Raveendran

Byju Raveendran What is Byju’s? Depending on whom you ask, answers range from a venture capital fund, a private equity fund, a proxy for the government’s education policy (or lack of it), or everyone’s favourite subject of memes or criticism. Byju’s, which has spent over $2 billion in acquisitions the…

Read more: Exclusive | China ed-tech crackdown will benefit India the most: Byju Raveendran

Rolex Rings IPO versus Glenmark Life Science IPO: Which one should you invest in?

Representative image It appears that the tide in the primary market is far from an ebb as there is a long list of companies that have expressed their intent to enter the Street soon. This week, the IPO of two companies – Glenmark Life Sciences and Rolex Rings – will open for…

Read more: Rolex Rings IPO versus Glenmark Life Science IPO: Which one should you invest in?

Fintech firms set for IPOs but face challenges

India’s fintech sector is set for landmark Initial Public Offerings (IPOs) in the next five months as at least three startups – Paytm, Mobikwik, Policybazaar – are likely to raise up to Rs 28,000 crore ($3.7 billion) through public offers betting on favourable market dynamics where both institutional and retail…

Read more: Fintech firms set for IPOs but face challenges

IPO Buzz | Carwale owner CarTrade Tech gets SEBI approval for Rs 2,000 crore public listing

Nykaa converts into public company ahead of IPO, renamed FSN e-commerce Ventures Ltd

Byju’s buys Great Learning, Toppr as $2-billion acquisition spree continues

Glenmark Life Science IPO or Rolex Rings IPO: Where should investors put their money?

Subscribe to Glenmark Life Sciences: Anand Rathi

BYJU's acquires learning app Toppr and upskilling platform Great Learning

Exclusive | KFC, Pizza Hut & Costa Coffee Operator Devyani International May Launch IPO On 4th August; 3rd QSR Listing Post Burger King & Barbecue Nation

Volvo Cars' earnings top pre-pandemic levels in boost ahead of possible IPO

OTHER NEWS